Secondary prevention in myocardial infarction survivors.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001792:Blood Platelets; D048909:Diabetes Complications; D004036:Diet, Atherogenic; D006801:Humans; D006973:Hypertension / Q000150:complications; D009203:Myocardial Infarction / Q000209:etiology / Q000517:prevention & control*; D005082:Physical Exertion; D012306:Risk; D012907:Smoking
D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants